News & Insights Get the latest insights on bedside cell and gene therapy from Lupagen. August 24, 2023 Fresenius Kabi and Lupagen enter into strategic development and supply agreement to bring cell and gene therapies to the bedside Read August 24, 2023 Fresenius Kabi and Lupagen enter into strategic development and supply agreement to bring cell and gene therapies to the bedside May 16, 2023 Potent In Vivo CAR T Cell Generation and Durable Antitumor Activity in Preclinical Models Using VivoVec, a Surface-Engineered Lentiviral Vector Drug Product American Society of Gene & Cell Therapy (ASGCT) 2023 Annual Meeting May 23, 2022 Umoja Biopharma and Lupagen Announce New Collaboration to Improve Patient Experience and Access to Next-Generation In Vivo Therapeutics for Cancer Email Address(Required) Δ Let’s redefine what’spos·si·blefor cell & gene therapy CONTACT US
